CIK 0000925741 · Non-accelerated filer<br>Smaller reporting company
BioCardia, Inc.
Sign in to watch- Ticker
- BCDA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 232753988
- Phone
- 650-226-0123
- Business address
- 320 SOQUEL WAY, SUNNYVALE, CA, 94085
- Former names
- Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
- Open-market buys, last 90 days
- $9,394
- in 5 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,394. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-23 | McClung David Chief Financial Officer | Grant or award | +4,280 | $2.34 | $10K | 135,724 |
| 2023-06-23 | Allen Jim L. Director | Grant or award | +64,212 | $2.34 | $150K | 894,743 |
| 2023-06-23 | Blank Andrew Scott Director | Grant or award | +64,212 | $2.34 | $150K | 211,404 |
| 2023-06-23 | STERTZER SIMON H Director | Grant or award | +64,212 | $2.34 | $150K | 267,766 |
| 2023-05-31 | GILLIS EDWARD M Senior Vice President, Devices | Shares withheld for taxes | −15,512 | $1.77 | $27K | 48,857 |
| 2023-05-31 | McClung David Chief Financial Officer | Shares withheld for taxes | −20,676 | $1.77 | $37K | 131,444 |
| 2023-05-31 | Altman Peter President and CEO | Shares withheld for taxes | −36,821 | $1.77 | $65K | 432,418 |
| 2023-05-26 | Altman Peter President and CEO | Purchase | +6,200 | $1.60 | $10K | 469,239 |
| 2023-05-18 | GILLIS EDWARD M Senior Vice President, Devices | Grant or award | +40,490 | $1.70 | $69K | 40,490 |
| 2023-05-18 | GILLIS EDWARD M Senior Vice President, Devices | Grant or award · Stock Option (right to buy) | +43,803 | 43,803 | ||
| 2023-05-18 | McClung David Chief Financial Officer | Grant or award | +61,389 | $1.70 | $104K | 152,120 |
| 2023-05-18 | McClung David Chief Financial Officer | Grant or award · Stock Option (right to buy) | +68,265 | 68,265 | ||
| 2023-05-18 | Altman Peter President and CEO | Grant or award | +109,324 | $1.70 | $186K | 463,039 |
| 2023-05-18 | Altman Peter President and CEO | Grant or award · Stock Option (right to buy) | +159,723 | 159,723 | ||
| 2022-12-16 | FROST PHILLIP MD ET AL 10% owner | Purchase | +595,238 | $1.68 | $1000K | 2,025,827 |
| 2022-12-16 | Allen Jim L. Director | Grant or award | +148,809 | $1.68 | $250K | 830,531 |
| 2022-12-16 | Blank Andrew Scott Director | Grant or award | +148,809 | $1.68 | $250K | 291,659 |
| 2022-12-16 | Altman Peter President and CEO | Grant or award | +14,880 | $1.68 | $25K | 347,827 |
| 2022-12-16 | STERTZER SIMON H Director | Grant or award | +178,571 | $1.68 | $300K | 888,084 |
| 2022-12-16 | McClung David Chief Financial Officer | Grant or award | +8,928 | $1.68 | $15K | 87,446 |
Page 9 of 14 · 273 trades